Sign In

CPG Infobase: Clinical Practice Guidelines


The CPG Infobase is a database of evidence-based Canadian clinical practice guidelines (CPGs). Maintained by Joule, a CMA company, it includes approximately 1,200 CPGs developed or endorsed by authoritative medical or health organizations in Canada.

List of Guidelines

For Subject: Deprescriptions
Number of CPGs:  8

  • Results 1-8
1.
Deprescribing benzodiazepine receptor agonists

View PDF
2018-May
Deprescribing Benzodiazepine Guideline Development Team

Detailed Result

2.
Déprescription des agonistes des récepteurs des benzodiazépines

View PDF
2018-mai
Deprescribing Benzodiazepine Guideline Development Team

Detailed Result

3.
Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia

View PDF
2018-Jan
Deprescribing Antipsychotics Guideline Development Team

Detailed Result

4.
Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie

View PDF
2018-janv
Deprescribing Antipsychotics Guideline Development Team

Detailed Result

5.
Deprescribing antihyperglycemic agents in older persons

View PDF
2017-Nov
Deprescribing Antihyperglycemic Agents Guideline Development Team

Detailed Result

6.
Déprescription des antihyperglycémiants chez les personnes âgées

View PDF
2017-nov
Deprescribing Antihyperglycemic Agents Guideline Development Team

Detailed Result

7.
Deprescribing proton pump inhibitors

View PDF
2017-May
Working Group on Deprescribing Proton Pump Inhibitors

Detailed Result

8.
Déprescrire les inhibiteurs de la pompe à protons

View PDF
2017-mai
Working Group on Deprescribing Proton Pump Inhibitors

Detailed Result



Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.